Abstract:Label-free quantitative approach based mass spectrometry was used for analysis of complex proteomes, meanwhile, a method based on quantitative analysis which is used for explaining functions and interactions in a large-scale manner is of great importance. To systematically overcome this challenge, we should build a method combing with quantitation and qualification. We used Normalized Spectral Abundance Factor (NSAF) based peptide count as starting point for our analysis and proposed a new method with shared peptides to accurately evaluate abundance of Isoforms for complex proteomes. In addition, large-scale functional annotations of complex proteomes were extracted by g:Profiler and analyzed in the process of quantitation. In this paper, three groups of mitochondrial proteins including mouse heart mitochondrial proteins, mouse liver mitochondrial proteins and human heart mitochondrial proteins were selected for analysis. All MS/MS spectra t were searched against the IPI mouse database and IPI human database using the pFind software kit. Detailed search parameters were performed using as follows: partial tryptic digest allowing two missed cleavages; fixed modification of cysteine with carbamidomethylation (57.021 Da) and variable modification of methionine with oxidation (15.995 Da), the precursor and fragment mass tolerances were set up at 1.5 and 0.5 Da, respectively. Peptides matching the following criteria were used for protein identification: DeltaCN >= 0.1; FDR <= 1.0%; peptide mass was 600.0 similar to 6000.0; peptide length was 6 similar to 60. According to the biochemical properties of mitochondrial proteins, all functional annotations were assigned to various signaling pathway or functional clusters, such as apoptosis, DNA/RNA/protein synthesis, metabolism, oxidative phosphorylation, protein binding/folding, proteolysis, redox, signal transduction, structure, transport, cell adhesion and cell cycle, and analyzed by correlation analysis, functional clustering and electron transport chain analysis. We found that proteins which rank have enormous variation between NSAF and the new method even came from a same family, such as proteins belonging to acyl-CoA dehydrogenase family. Proteins in the family play an important role in life event due to their biochemical properties of fatty acid metabolism and lipid metabolism searched using the online database analysis tool available through UniProt (www.uniprot.org). From the global perspective of the three groups of mitochondrial proteins, the correlation of mouse heart mitochondrial proteins and mouse liver mitochondrial proteins shows highest, while the correlation of human heart mitochondrial proteins and mouse liver mitochondrial proteins shows lowest, it denotes that the correlation of simple species and different organs shows highest. On the aspect of functional clustering, metabolic proteins have highest abundance in mouse liver mitochondrial dataset, while oxidative phosphorylation proteins show highest abundance in cardiac mitochondrial dataset. This explains that liver plays an important role in metabolic process including nutrients synthesis, transformation and decomposition, however, heart promotes blood flowing to provide adequate blood to the organs or tissues, supply oxygen or various nutrients and take metabolic products away. We concluded that the strategy with shared peptides overcame inaccurate and overestimated results to improve accuracy, and label-free quantitative approach coupled with complex proteome functional analysis can thoroughly explore protein functions or relationship and provide a new method for large-scale comparative or diseased proteomics.

Computational Advances in the Label-free Quantification of Cancer Proteomics Data.

Comparative evaluation of label-free quantification strategies.

Quantitative proteomics for cancer biomarker discovery.

Simultaneous Improvement in the Precision, Accuracy, and Robustness of Label-free Proteome Quantification by Optimizing Data Manipulation Chains.

Advances in the Application of Proteomics in Lung Cancer

Development of Algorithms for Mass Spectrometry-based Label-free Quantitative Proteomics

Quantitative Proteomics Characterization of Cancer Biomarkers and Treatment

Computational Advances of Tumor Marker Selection and Sample Classification in Cancer Proteomics

QuantFusion: Novel Unified Methodology for Enhanced Coverage and Precision in Quantifying Global Proteomic Changes in Whole Tissues

Computational Analysis and Comparison of Continuous and Count-based Label-free Quantitative Proteomic Data

Improvement Of The Quantification Accuracy And Throughput For Phosphoproteome Analysis By A Pseudo Triplex Stable Isotope Dimethyl Labeling Approach

Recent Technological Advances in the Mass Spectrometry-based Nanomedicine Studies: an Insight from Nanoproteomics.

Label-Free Protein Quantification Using Lc-Coupled Ion Trap or Ft Mass Spectrometry: Reproducibility, Linearity, and Application with Complex Proteomes

Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers

Label--free Protein Quantification Methods in Proteomics Research

Quantitative Proteomics and Biomarker Discovery in Human Cancer

A Mass Spectrometry-based Label-free Quantitative Approach Coupled With Complex Proteome Functional Analysis

Mass Spectrometry-Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right Steps

Clinical Proteomics-Driven Precision Medicine for Targeted Cancer Therapy: Current Overview and Future Perspectives

Biotransformation-based Metabolomics Profiling Method for Determining and Quantitating Cancer-Related Metabolites.

Advances in Proteomics and Bioinformatics